# Tisseel® as a Reinforcement of Esophagojejunal Anastomoses

> **NCT03733639** · PHASE4 · UNKNOWN · sponsor: **Germans Trias i Pujol Hospital** · enrollment: 146 (estimated)

## Conditions studied

- Gastric Cancer
- Anastomotic Leak

## Interventions

- **DRUG:** Tisseel
- **DEVICE:** No Tisseel

## Key facts

- **NCT ID:** NCT03733639
- **Lead sponsor:** Germans Trias i Pujol Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-21
- **Primary completion:** 2021-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 146 (ESTIMATED)
- **Last updated:** 2020-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03733639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03733639, "Tisseel® as a Reinforcement of Esophagojejunal Anastomoses". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT03733639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*